January 14, 2010

Grant Aims to Identify, Reduce Suicide Among E.R. Patients

Author Info

Reviewed by: 
Joseph V. Madia, MD By:

Article Rating

3.45
Average: 3.5 (2 votes)
Your rating: None

A new grant funded by the National Institute of Mental Health aims to increase suicide detection and prevention efforts among patients who present with suicide risk factors in hospital emergency departments.
The Emergency Department Safety Assessment and Follow-up Evaluation (EDSAFE) trial will be coordinated by the Emergency Medicine Network, based at the University of Massachusetts. The team of researchers will be led by Edwin D. Boudreaux, Ph.D., and Carlos A. Camargo, Jr., M.D., Dr.P.H., both of the University of Massachusetts, and Ivan Miller, Ph.D., of Butler Hospital in Providence, Rhode Island. The project is expected to enroll nearly 1,420 participants over five years.

EDSAFE will be conducted in three phases. The first phase will assess treatment as usual (TAU) for patients. TAU typically consists of evaluating suicidal risk only among those E.R. patients who have psychiatric risk factors such as depression, substance abuse or suicidal thinking or behavior (ideation). Often these patients are put under observation while at the hospital and are evaluated by a mental health provider. They also may be referred to a mental health professional outside the hospital, but few receive adequate follow-up care after they are discharged.

During the second phase, a universal screening process will be tested in which all patients, regardless of whether they exhibit typical risk factors for suicide, will be screened for suicidal ideation. The researchers will compare universal screening with TAU to determine how well each detects suicidal patients.

During the third phase, a more intensive intervention that includes screening, brief counseling, an evaluation by a mental health provider, referral to outpatient care and other components will be implemented. Patients will then receive follow-up phone counseling. The intensive intervention will be compared to TAU and to universal screening.

The study will be conducted at eight sites throughout the nation and is set to begin in June 2010.

Contact:
Colleen Labbe
301-443-4536
[email protected]

Share this story:

Reviewed by: 
Joseph V. Madia, MD
Review Date: 
September 21, 2010

Last Updated:
December 3, 2013